(Q38030051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

main subject

angiogenesis inhibitor

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Teresa Di Desidero

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Marco Nardi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Romano Danesi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Elisa Agosta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stefano Lazzeri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Paola Orlandi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anna Fioravanti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Maria Sole Sartini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Guido Bocci

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1037-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22838951%20AND%20SRC:MED&resulttype=core&format=json

Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

9 February 2020

cites work

1 reference

Review of genetics in age related macular degeneration.

21 January 2018

1 reference

Age-Related Macular Degeneration

21 January 2018

1 reference

Vascular endothelial growth factors and angiogenesis in eye disease

21 January 2018

1 reference

Growth factors in age-related macular degeneration: pathogenic and therapeutic implications

21 January 2018

1 reference

Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy

21 January 2018

1 reference

Vascular endothelial growth factor biology: clinical implications for ocular treatments

21 January 2018

1 reference

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

21 January 2018

1 reference

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

21 January 2018

1 reference

Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.

21 January 2018

1 reference

Increased expression of angiogenic growth factors in age-related maculopathy

21 January 2018

1 reference

VEGF polymorphisms are associated with neovascular age-related macular degeneration.

21 January 2018

1 reference

Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study

21 January 2018

1 reference

Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration.

21 January 2018

1 reference

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor

21 January 2018

1 reference

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

Complement factor H polymorphism and age-related macular degeneration

21 January 2018

1 reference

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

21 January 2018

1 reference

Complement factor H variant increases the risk of age-related macular degeneration

21 January 2018

1 reference

Complement activation and inflammatory processes in Drusen formation and age related macular degeneration

21 January 2018

1 reference

Systemic complement activation in age-related macular degeneration

21 January 2018

1 reference

The complement system and age-related macular degeneration.

21 January 2018

1 reference

21 January 2018

1 reference

A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions

21 January 2018

1 reference

Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration

21 January 2018

1 reference

21 January 2018

1 reference

C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration

21 January 2018

1 reference

Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

21 January 2018

1 reference

21 January 2018

1 reference

A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration

21 January 2018

1 reference

Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria

21 January 2018

1 reference

ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations

21 January 2018

1 reference

Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-beta signaling

21 January 2018

1 reference

Mitotic misregulation and human aging

21 January 2018

1 reference

The role of human HtrA1 in arthritic disease

21 January 2018

1 reference

HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins

21 January 2018

1 reference

HTRA1 promoter polymorphism in wet age-related macular degeneration

21 January 2018

1 reference

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration

21 January 2018

1 reference

Rhesus monkeys and humans share common susceptibility genes for age-related macular disease

21 January 2018

1 reference

Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients

21 January 2018

1 reference

Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration

21 January 2018

1 reference

Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking

21 January 2018

1 reference

HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population

21 January 2018

1 reference

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

A role for local inflammation in the formation of drusen in the aging eye.

21 January 2018

1 reference

Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane

21 January 2018

1 reference

Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population

21 January 2018

1 reference

Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center

21 January 2018

1 reference

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies

21 January 2018

1 reference

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

21 January 2018

1 reference

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

21 January 2018

1 reference

Treatment of proliferative diabetic retinopathy with anti-VEGF agents

21 January 2018

1 reference

Aptamers, intramers, and vascular endothelial growth factor

21 January 2018

1 reference

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

21 January 2018

1 reference

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

21 January 2018

1 reference

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up

21 January 2018

1 reference

A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(R) (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: c

21 January 2018

1 reference

Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study

21 January 2018

1 reference

Exudative age-related macular degeneration: efficacy and limits of the different treatments

21 January 2018

1 reference

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

21 January 2018

1 reference

The biology of VEGF and its receptors

21 January 2018

1 reference

Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

21 January 2018

1 reference

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

21 January 2018

1 reference

Ranibizumab therapy for neovascular age-related macular degeneration

21 January 2018

1 reference

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

21 January 2018

1 reference

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study

21 January 2018

1 reference

Treatment patterns for neovascular age-related macular degeneration: analysis of 284 380 medicare beneficiaries

21 January 2018

1 reference

Science, medicine, and the future: Pharmacogenetics

21 January 2018

1 reference

Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration

21 January 2018

1 reference

Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.

21 January 2018

1 reference

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

21 January 2018

1 reference

Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration

21 January 2018

1 reference

An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.

21 January 2018

1 reference

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy

21 January 2018

1 reference

Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration

21 January 2018

1 reference

Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.

21 January 2018

1 reference

Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration

21 January 2018

1 reference

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab

21 January 2018

1 reference

Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.

21 January 2018

1 reference

CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration

21 January 2018

1 reference

Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.

21 January 2018

1 reference

Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD.

21 January 2018

1 reference

CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration

21 January 2018

1 reference